Mergers & Acquisitions - Mergers & Acquisitions, Generics

Filter

Popular Filters

76 to 100 of 179 results

Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma

10-07-2013

Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

Mylan stumbles in $1.6 billion bid to take over injectables specialist Agila Specialties in India

09-07-2013

US generics and specialty drugs company Mylan (NYSE: MYL) faces a setback in its plan to acquire Indian…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesStrides Arcolab

South Africa's Adcock Ingram confirms takeover bid from CFR Pharma

04-07-2013

In what was described as a "cautionary" statement, South Africa's largest drugmaker Adcock Ingram (AIP:…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Mayne Pharma makes second US acquisition, this time generic drugmaker Libertas

03-07-2013

In a second move into the US market in less than a year, Australia's Mayne Pharma (ASX: MYX) says it…

GenericsLibertas PharmaMayne PharmaMergers & Acquisitions

Perrigo acquires ophthalmic portfolio from Fera Pharma for initial $93 million

18-06-2013

Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed…

Fera PharmaceuticalsGenericsMergers & AcquisitionsOphthalmicsPerrigo

Fujifilm and Dr Reddy's abandon plans for generics JV in Japan

04-06-2013

Japan's Fujifilm Corp and Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) have decided to terminate…

Dr Reddy's LaboratoriesFujifilmGenericsMergers & AcquisitionsProduction

Novo A/S acquires Norway's Xellia Pharmaceuticals in $700 million deal

21-05-2013

Denmark-based Novo A/S, the holding company of the Novo Group and the major shareholder in Novo Nordisk…

Antibiotics and Infectious diseasesGenericsMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalXellia Pharmaceuticals

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal

20-05-2013

US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

Sagent Pharma to buy remaining 50% stake in Chinese JV for $25 million

06-05-2013

US specialty pharmaceutical company Sagent Pharmaceuticals (Nasdaq: SGNT) has entered into an agreement…

Asia-PacificGenericsKanghong Sagent (Chengdu) PharmaceuticalMergers & AcquisitionsPharmaceuticalProductionSagent Pharmaceuticals

Arseus/Fagron acquire US pharma compounder Freedom Pharma

01-05-2013

USA-based Freedom Pharmaceuticals says that it has been acquired by Arseus, the holding company for Fagron,…

ArseusFagronFreedom PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Actavis in OxyContin patent settlement; Valeant takeover bid "on hold"?

29-04-2013

US generic major Actavis (NYSE: ACT) has entered into an agreement with privately-held Purdue Pharma…

ActavisGenericsMergers & AcquisitionsNeurologicalNorth AmericaOxyContinPatentsPurdue PharmaValeant Pharmaceuticals

Hikma to retain its global Injectables business

17-04-2013

Further to its announcement last month that it was undertaking a review of the strategic options for…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

BioSante Pharma and ANI Pharma amend merger terms

15-04-2013

USA-based BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) and privately-held specialty and generic drugmaker…

ANI PharmaceuticalsBioSante PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Adcock Ingram rejects Bidvest approach as opportunistic

04-04-2013

South African generics drugmaker Adcock Ingram (AIP: SJ) has confirmed a non-binding approach from Bidvest…

Adcock IngramGenericsMergers & Acquisitions

Merz Pharma enters bidding war for Obagi; Ferro sells pharma unit

02-04-2013

German family-owned firm Merz Pharma has written to the board of director of Obagi Medical Products outlining…

Ferro GroupGenericsMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPfanstiehl LaboratoriesPharmaceuticalValeant Pharmaceuticals

Amdipharm and Mercury Pharma merge

15-03-2013

As has been expected, Amdipharm and Mercury Pharma - both subsidiaries of Channel Islands-based private…

Amdipharm Mercury CompanyGenericsMercury PharmaMergers & Acquisitions

Hikma leaps as it confirms unsolicited interest in Injectables business

04-03-2013

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Indian pharma excipients distributor IndChem acquired by Dutch firm IMCD

20-02-2013

Netherlands-based conglomerate IMCD Group BV has acquired the business of IndChem International, an established…

GenericsIMCD GroupIndChemMergers & AcquisitionsPharmaceutical

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal

12-02-2013

The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Perrigo acquires UK drugmaker Rosemont for £180 million

12-02-2013

USA-based Perrigo (Nasdaq: PRGO) has signed a definitive merger agreement and has completed the acquisition…

GenericsMergers & AcquisitionsPerrigoPharmaceuticalRosemont Pharmaceuticals

Aduro BioTech buys all GVAX assets from BioSante; Aspen in talks to buy Merck unit

05-02-2013

Aduro BioTech, a privately-held, US venture capital backed biotechnology company, says it has acquired…

Aduro BioTechAspen PharmacareBioSante PharmaceuticalsBiotechnologyGenericsGVAXImmunologicalsMerck & CoMergers & AcquisitionsOncologyVaccines

76 to 100 of 179 results

Back to top